What is the recommended treatment for Clostridium difficile (C. difficile) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Clostridium difficile Infection

For initial episodes of C. difficile infection (CDI), either vancomycin 125 mg orally four times daily or fidaxomicin 200 mg orally twice daily for 10 days is recommended over metronidazole as first-line therapy. 1, 2

Treatment Algorithm Based on Disease Severity

Initial Episode Classification and Treatment

Non-severe CDI (Adults)

  • Definition: WBC ≤15,000 cells/mL and serum creatinine <1.5 mg/dL 1, 2
  • Treatment:
    • Vancomycin 125 mg orally four times daily for 10 days 1, 3
    • OR Fidaxomicin 200 mg orally twice daily for 10 days 1, 4
    • Discontinue the inciting antibiotic as soon as possible 1, 2

Severe CDI (Adults)

  • Definition: WBC ≥15,000 cells/mL or serum creatinine >1.5 mg/dL 1, 2
  • Treatment:
    • Vancomycin 125 mg orally four times daily for 10 days 1
    • OR Fidaxomicin 200 mg orally twice daily for 10 days 1, 4

Fulminant CDI (Adults)

  • Definition: Hypotension, shock, ileus, or megacolon 1
  • Treatment:
    • Vancomycin 500 mg orally four times daily 1, 2
    • PLUS intravenous metronidazole 500 mg every 8 hours 1
    • If ileus present: Add rectal vancomycin 500 mg in 100 mL normal saline every 6 hours as retention enema 1, 2

Pediatric Treatment (6 months to <18 years)

Non-severe CDI

  • Treatment:
    • Vancomycin 10 mg/kg/dose (maximum 125 mg) orally four times daily for 10 days 1, 2
    • OR Metronidazole 7.5 mg/kg/dose (maximum 500 mg) orally three or four times daily for 10 days 1

Severe/Fulminant CDI

  • Treatment:
    • Vancomycin 10 mg/kg/dose (maximum 500 mg) orally four times daily for 10 days 1
    • Consider adding intravenous metronidazole if critically ill 1

Management of Recurrent CDI

First Recurrence

  • If metronidazole was used for initial episode:

    • Vancomycin 125 mg orally four times daily for 10 days 1, 2
  • If standard vancomycin was used for initial episode:

    • Tapered and pulsed vancomycin regimen (e.g., 125 mg four times daily for 10-14 days, then twice daily for 7 days, then once daily for 7 days, then every 2-3 days for 2-8 weeks) 1, 2
    • OR Fidaxomicin 200 mg orally twice daily for 10 days 1, 5

Second or Subsequent Recurrence

  • Options include:
    • Vancomycin in a tapered and pulsed regimen 1, 2
    • Vancomycin 125 mg four times daily for 10 days, followed by rifaximin 400 mg three times daily for 20 days 1
    • Fidaxomicin 200 mg twice daily for 10 days 1
    • Fecal microbiota transplantation (after failing appropriate antibiotic treatments) 1, 2

Monitoring Treatment Response

  • Expect decreased stool frequency and improved consistency within 3 days of starting treatment 2
  • If no improvement after 3-5 days, reassess severity and consider alternative diagnoses 2

Important Considerations and Pitfalls

  • Avoid metronidazole for severe CDI: Despite its lower cost, metronidazole is less effective than vancomycin for severe cases and should be reserved only for non-severe cases when access to vancomycin/fidaxomicin is limited 1

  • Discontinue inciting antibiotics: Failure to stop the triggering antibiotic significantly increases recurrence risk 1, 2

  • Avoid antiperistaltic agents: These can mask symptoms and potentially worsen disease 2

  • Dosing controversy: While some studies have examined higher doses of vancomycin for severe CDI, current evidence does not support routine use of doses higher than those recommended in guidelines 6, 7, 8

  • Recurrence prevention: Fidaxomicin has shown superiority in preventing recurrence compared to vancomycin (19.7% vs 35.5% recurrence rates) 5

  • Surgical consultation: Early surgical evaluation is recommended for patients with perforation, systemic inflammation not responding to antibiotics, toxic megacolon, severe ileus, or serum lactate >5.0 mmol/L 2

  • Vancomycin absorption: While oral vancomycin is minimally absorbed, patients with inflammatory bowel disorders may have significant systemic absorption, requiring monitoring in those with renal insufficiency 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Clostridium difficile Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.